Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.83 |
| ▸ | LPL | P06858 | 12/20 | 0.83 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | F11 | P03951 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.44 |
| ▸ | P4HB | P07237 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24608995 | 1.00 | LIPG (0.83) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL12681706 | 0.93 | LIPG (0.74) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL28389622 | 0.93 | LIPG (0.88) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL228212 | 0.92 | LPL (0.71) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL18134357 | 0.91 | LIPG (1.00) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL476870 | 0.91 | LIPG (1.00) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL18270366 | 0.91 | LIPG (1.00) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL10021061 | 0.91 | LIPG (1.00) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL4470995 | 0.91 | LIPG (0.71) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL4470992 | 0.89 | LIPG (0.69) | LIPGLPLCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116870962-A | Multiphase nitrogen-containing ligand modified supported ruthenium catalyst and preparation and application thereof | 中国科学院兰州化学物理研究所 | 2023-10-13 | — | — | CN | claimed |
| CN-114602425-B | Plasma activated carbon regeneration method taking hydrogen peroxide as secondary excitation object | 上海鎏明科技有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-114602425-A | Plasma activated carbon regeneration method using hydrogen peroxide as secondary excitation object | 上海鎏明科技有限公司 | 2022-06-10 | — | — | CN | claimed |
| EP-4051667-B1 | HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS | LILAC THERAPEUTICS INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250064787-A1 | Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors | LILAC THERAPEUTICS INC (US) | 2025-02-27 | — | — | US | disclosed |
| EP-4470538-A2 | HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS | Lilac Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| US-12071503-B2 | Method for preparing and repairing covalent organic framework materials | ZHEJIANG UNIVERSITY (CN) | 2024-08-27 | — | — | US | disclosed |
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | Lilac Therapeutics, Inc. (US) | 2023-11-07 | — | — | US | disclosed |
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | Lilac Therapeutics, Inc. (US) | 2023-11-07 | — | — | US | disclosed |
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | Lilac Therapeutics, Inc. (US) | 2023-11-07 | — | — | US | disclosed |
| CN-116870962-A | Multiphase nitrogen-containing ligand modified supported ruthenium catalyst and preparation and application thereof | 中国科学院兰州化学物理研究所 | 2023-10-13 | — | — | CN | disclosed |
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEM, LTD. (KR) | 2011-07-14 | — | — | US | disclosed |
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEM, LTD. (KR) | 2011-07-14 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| US-20090091244-A1 | AMINE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC BLUE-LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091244-A1 | AMINE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC BLUE-LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090048413-A1 | Method for Production of Conjugated Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-02-19 | — | — | US | disclosed |
| EP-1997844-A1 | METHOD FOR PRODUCTION OF CONJUGATED POLYMER | Sumitomo Chemical Company, Limited (JP) | 2008-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | UGDH, PGD, PNPO | LIPG 197/4885LPL 660/4885CA1 611/4885 |
| US-20090091244-A1 | AMINE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC BLUE-LIGHT-EMITTING DEVICE | TYR, AOC2, CRY1 | LIPG 2758/4885LPL 1831/4885CA1 4347/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | LIPG 1280/4885LPL 2383/4885CA1 4745/4885 |
| US-20110168992-A1 | NOVEL COMPOUND, METHOD FOR PREPARING SAME AND ORGANIC ELECTRONIC DEVICE USING SAME | OR10J3, USE1, NOTUM | LIPG 1928/4885LPL 3043/4885CA1 4266/4885 |
| US-20250064787-A1 | Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors | GLS, DUOX1, HAO1 | LIPG 1139/4885LPL 1856/4885CA1 205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.